Citations

Mayo Clinic

Showing 10 of 108599 citations.

Safety and efficacy of human platelet extract in skin recovery after fractional CO2 laser resurfacing of the face: A randomized, controlled, evaluator‐blinded pilot study
Dayan, Steven , Gandhi, Nimit , Wilson, John A. , Kola, Eljona, Jankov, Laura Eaton, Copeland, Karen , Paradise, Christopher R. , van Wijnen, Andre J , Wilson, John , Wilson, John, Behfar, Atta

Journal of Cosmetic Dermatology | July 7, 2023 | Volume: 22 | Issue: 9 | Pages: 2464-2470

10.1111/jocd.15914 | PMID 37417644 Get It

AbstractBackgroundFractional carbon dioxide (CO2) laser resurfacing is used successfully for facial rejuvenation. Post procedure skincare is a variable that influences downtime caused by pain/tenderness, erythema, crusting, and bruising.AimsThe primary objective of this pilot study was to demonstrate the benefits of human platelet extract (HPE) (plated)™ CALM Serum, a new topical cosmetic product, following fractionated CO2 ablative laser resurfacing treatment to the entire face versus standard of care.MethodsIn a single‐center, randomized, evaluator‐blinded pilot study, a total of 18 subjects were randomized into two groups, CO2 facial resurfacing followed by post‐procedural standard of care (Stratacel silicone gel) or CO2 facial resurfacing with the addition of HPE renewosomes in the CALM Serum.ResultsCALM Serum demonstrated statistically significant less crusting at Day 10 compared to the control group (p = 0.0193) with less downtime in the first 14 days (p = 0.03). Subjects treated with CALM Serum had statistically significant brighter appearing skin at 14 days (p = 0.007) and more youthful looking skin on Days 14 and 30 (p = 0.003 and 0.04, respectively).ConclusionsThis study demonstrates that Renewosome™ technology provides statistically significant post‐laser clinical recovery over silicone gel for reducing crusting, and downtime. Subjects reported less diary days of symptoms of pain/tenderness, redness, crusting/flaking, bruising, and itching in the first 14 days compared to the control group. CALM also demonstrated statistically significant improvements in brighter and more youthful appearing skin. CALM is safe and well tolerated.
Outbreak of Sudan Ebola virus in Uganda, a threat to collapsing health care system and beyond
Nadeem, Hania, Yaqoob, Muhammad M. , Ali, Eman , Shahnawaz, Waqas, Tahir, Haya Muhammad, Asghar, Muhammad Sohaib , Asghar, Muhammad S , Yaqoob, Muhammad, Rehan, Syeda Tayyaba , Ullah, Irfan

International Journal of Surgery: Global Health | July 7, 2023 | Volume: 6 | Issue: 4 | Pages: No page available

10.1097/gh9.0000000000000174 Get It

Forever chemicals: the ugly side of cosmetics
Shaikh, Omer Ahmed , Fatima, Areej , Shekha, Manahil, Kumar, Lakshya, Jaykumar, Vadodarya, Resham, Asghar, Muhammad Sohaib , Asghar, Muhammad S , Kumar, Lakshya, Ullah, Irfan

International Journal of Surgery: Global Health | July 7, 2023 | Volume: 6 | Issue: 4 | Pages: No page available

10.1097/gh9.0000000000000173 Get It

Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
McGlothlin, John , Abeykoon, Jithma P. , Al‐Hattab, Eyad, Ashrani, Aneel A. , Elliott, Michelle A. , Hook, C. Christopher , Pardanani, Animesh , Pruthi, Rajiv K. , Sridharan, Meera , Wolanskyj, Alexandra P., Rouse, Rachelle, Elliott, Michelle , Pruthi, Rajiv, Wolanskyj, Alexandra, Sridharan, Meera , Go, Ronald S.

American Journal of Hematology | July 7, 2023 | Volume: 98 | Issue: 10 | Pages: No page available

10.1002/ajh.27025 | PMID 37417424 Get It

Immune-Checkpoint Inhibitors in the Hepatitis C–Infected Patient: To Use or Not to Use?
Barnhill, Michele , Vargas, Hugo E. , Barnhill, Michele S, Vargas, Hugo E

American Journal of Gastroenterology | July 7, 2023 | Volume: 118 | Issue: 9 | Pages: 1554-1555

10.14309/ajg.0000000000002352 | PMID 37417784 Get It

The impact of primary peristalsis, contractile reserve, and secondary peristalsis on esophageal clearance measured by timed barium esophagogram
Koop, Andree , Kahrilas, Peter J. , Schauer, Jacob M. , Pandolfino, John E. , Carlson, Dustin A. , Koop, Andree H

Neurogastroenterology & Motility | July 7, 2023 | Volume: 35 | Issue: 10 | Pages: No page available

10.1111/nmo.14638 | PMID 37417394 Get It

AbstractBackgroundPrimary and secondary peristalsis facilitate esophageal bolus transport; however, their relative impact for bolus clearance remains unclear. We aimed to compare primary peristalsis and contractile reserve on high‐resolution manometry (HRM) and secondary peristalsis on functional lumen imaging probe (FLIP) Panometry with emptying on timed barium esophagogram (TBE) and incorporate findings into a comprehensive model of esophageal function.MethodsAdult patients who completed HRM with multiple rapid swallows (MRS), FLIP, and TBE for esophageal motility evaluation and without abnormal esophagogastric junction outflow/opening or spasm were included. An abnormal TBE was defined as a 1‐min column height >5 cm. Primary peristalsis and contractile reserve after MRS were combined into an HRM–MRS model. Secondary peristalsis was combined with primary peristalsis assessment to describe a complementary neuromyogenic model.Key ResultsOf 89 included patients, differences in rates of abnormal TBEs were observed with primary peristalsis classification (normal: 14.3%; ineffective esophageal motility: 20.0%; absent peristalsis: 54.5%; p = 0.009), contractile reserve (present: 12.5%; absent: 29.3%; p = 0.05), and secondary peristalsis (normal: 9.7%; borderline: 17.6%; impaired/disordered: 28.6%; absent contractile response: 50%; p = 0.039). Logistic regression analysis (akaike information criteria, area under the receiver operating curve) demonstrated that the neuromyogenic model (80.8, 0.83) had a stronger relationship predicting abnormal TBE compared to primary peristalsis (81.5, 0.82), contractile reserve (86.8, 0.75), or secondary peristalsis (89.0, 0.78).Conclusions and InferencesPrimary peristalsis, contractile reserve, and secondary peristalsis were associated with abnormal esophageal retention as measured by TBE. Added benefit was observed when applying comprehensive models to incorporate primary and secondary peristalsis supporting their complementary application.
Coronary Reactivity Assessment Is Associated With Lower Health Care–Associated Costs in Patients Presenting With Angina and Nonobstructive Coronary Artery Disease
Ahmad, Ali , Kanaji, Yoshihisa , Rosedahl, Jordan K., Gulati, Rajiv , Rihal, Charanjit S. , Sara, Jaskanwal Deep Singh , Toya, Takumi , Horst, Iris ter, Lerman, Lilach O. , Moriarty, James P. , Kanaji, Yoshihisa , Gulati, Rajiv , Sara, Jaskanwal D, Toya, Takumi , Lerman, Lilach O , Lerman, Amir , Corban, Michel , Rihal, Charanjit S. , Prasad, Abhiram , Borah, Bijan J. , Lerman, Amir

Circulation: Cardiovascular Interventions | July 7, 2023 | Volume: 16 | Issue: 7 | Pages: No page available

10.1161/circinterventions.122.012387 | PMID 37417227 Get It

BACKGROUND: The financial burden linked to the diagnosis and treatment of patients with chest pain on the health care system is considerable. Angina and nonobstructive coronary artery disease (ANOCA) is common, associated with adverse cardiovascular events, and may lead to repeat testing or hospitalizations. Diagnostic certainty can be achieved in patients with ANOCA using coronary reactivity testing (CRT); however, its financial effect on the patient has not been studied. Our goal was to assess the effect of CRT on health care–related cost in patients with ANOCA. METHODS: Patients with ANOCA who underwent diagnostic coronary angiography (CAG) and CRT (CRT group) were matched to controls who had similar presentation but only underwent a CAG without CRT (CAG group). Standardized inflation-adjusted costs were collected and compared between the 2 groups on an annual basis for 2 years post the index date (CRT or CAG). RESULTS: Two hundred seven CRT and 207 CAG patients were included in the study with an average age of 52.3±11.5 years and 76% females. The total cost was significantly higher in the CAG group as compared with the CRT group ($37 804 [$26 933–$48 674] versus $13 679 [$9447–$17 910]; P <0.001). When costs are itemized and divided based on the Berenson-Eggers Type of Service categorization, the largest cost difference occurred in imaging (any type, including CAG; P <0.001), procedures (eg, percutaneous coronary intervention/coronary artery bypass grafting/thrombectomy) ( P =0.001), and test (eg, blood tests, EKG; P <0.001). CONCLUSIONS: In this retrospective observational study, assessment of CRT in patients with ANOCA was associated with significantly reduced annual total costs and health care utilization. Therefore, the study may support the integration of CRT into clinical practice.
Factors Associated With Improved Pediatric Resuscitative Care in General Emergency Departments
Auerbach, Marc , Whitfill, Travis , Montgomery, Erin , Leung, James , Kessler, David , Gross, Isabel T. , Walsh, Barbara , Hamilton, Melinda, Gawel, Marcie, Kant, Shruti, Janofsky, Stephen , Brown, Linda , Walls, Theresa A. , Alletag, Michelle, Sessa, Anna , Arteaga, Grace M. , Keilman, Ashley , Ittersum, Wendy Van, Rutman, Maia S. , Zaveri, Pavan , Good, Grace , Schoen, Jessica C. , Lavoie, Meghan B., Mannenbach, Mark S., Bigham, Ladonna, Rutledge, Chrystal , Okada, Pamela J. , Moegling, Michelle , Anderson, Ingrid , Tay, Khoon‐Yen , Scherzer, Daniel , Vora, Samreen , Gaither, Stacy , Fenster, Daniel, Jones, Derick D. , Chatfield, Jenny, Knight, Lynda, Berg, Marc , Makharashvili, Ana, Katznelson, Jessica , Mathias, Emily, Lutfi, Riad , Abu‐Sultaneh, Samer , Padlipsky, Patricia, Lee, Jumie , Butler, Lucas, Alander, Sarah W., Bhatnagar, Ambika , Crellin, Jason, Mannenbach, Mark, Jones, Derick, Sessa, Anna, Lavoie, Meghan, Dudas, Robert Arthur , Aebersold, Michelle , Burns, Brian, Thomas, Anita Anne , Jafri, Farrukh Nadeem , Abulebda, Kamal

Pediatrics | July 7, 2023 | Volume: 152 | Issue: 2 | Pages: No page available

10.1542/peds.2022-060790 | PMID 37416979 Get It

OBJECTIVES To describe the quality of pediatric resuscitative care in general emergency departments (GEDs) and to determine hospital-level factors associated with higher quality. METHODS Prospective observational study of resuscitative care provided to 3 in situ simulated patients (infant seizure, infant sepsis, and child cardiac arrest) by interprofessional GED teams. A composite quality score (CQS) was measured and the association of this score with modifiable and nonmodifiable hospital-level factors was explored. RESULTS A median CQS of 62.8 of 100 (interquartile range 50.5–71.1) was noted for 287 resuscitation teams from 175 emergency departments. In the unadjusted analyses, a higher score was associated with the modifiable factor of an affiliation with a pediatric academic medical center (PAMC) and the nonmodifiable factors of higher pediatric volume and location in the Northeast and Midwest. In the adjusted analyses, a higher CQS was associated with modifiable factors of an affiliation with a PAMC and the designation of both a nurse and physician pediatric emergency care coordinator, and nonmodifiable factors of higher pediatric volume and location in the Northeast and Midwest. A weak correlation was noted between quality and pediatric readiness scores. CONCLUSIONS A low quality of pediatric resuscitative care, measured using simulation, was noted across a cohort of GEDs. Hospital factors associated with higher quality included: an affiliation with a PAMC, designation of a pediatric emergency care coordinator, higher pediatric volume, and geographic location. A weak correlation was noted between quality and pediatric readiness scores.
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository
Farber, Harrison W. , Chakinala, Murali M. , Cho, Michelle, Frantz, Robert P. , Frick, Andrew , Lancaster, Lisa , Milligan, Scott , Oudiz, Ronald J. , Panjabi, Sumeet , Tsang, Yuen, Nathan, Steven D. , Frantz, Robert P , Oudiz, Ronald

Pulmonary Circulation | July 7, 2023 | Volume: 13 | Issue: 3 | Pages: No page available

10.1002/pul2.12258 | PMID 37427090 Get It

AbstractPulmonary arterial hypertension (PAH) is a rare, life‐limiting disease. PAH registries provide real‐world data that complement clinical trial data and inform treatment decisions. The TRIO comprehensive, integrated patient data repository (TRIO CIPDR), is an innovative US repository capturing data on contemporary patients diagnosed with pulmonary hypertension and receiving US Food and Drug Administration‐approved PAH therapies. This repository uniquely combines clinical data from electronic medical records with the ability to track drug‐prescription and drug‐dispensing characteristics, and includes 946 adult patients with PAH (data collected January 2019 to December 2020) enrolled from nine representative US specialist tertiary care centers. Potentially eligible patients were identified based on dispensing data from specialty pharmacies. Hemodynamic and clinical data, as well as dispensing information on prescribed PAH medications, were provided by tertiary centers. At enrollment, 75% of patients were female, 67% were White, median age at PAH diagnosis was 53 years (median time from diagnosis to enrollment was 5 years), and 37% were obese. Comorbidity profiles were as expected for a PAH population, although the proportion with atrial fibrillation (34%) was higher than expected. Overall, 38% of patients had idiopathic PAH and 30% had connective tissue disease‐related PAH. Among 917 patients receiving PAH‐specific therapy, 40% were on monotherapy, 43% on dual therapy, and 17% on triple therapy. Longitudinal data from this repository will allow tracking of the PAH treatment journey in relation to clinical characteristics and outcomes.